Zhejiang Wecome Pharmaceutical Company Limited reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 314.19 million compared to CNY 293.63 million a year ago. Revenue was CNY 316.44 million compared to CNY 295.62 million a year ago.

Net income was CNY 64.62 million compared to CNY 56.99 million a year ago. Basic earnings per share from continuing operations was CNY 0.4463 compared to CNY 0.3936 a year ago. Diluted earnings per share from continuing operations was CNY 0.4463 compared to CNY 0.3936 a year ago.